News
We bring you up to date at all times: Discover the latest industry news from biotechnology, pharmaceuticals and life sciences. Researched by us so you don't have to.
Selected departments
Selected industries
Companies
The Who's Who of Life Sciences: Discover companies from all over the world. Here you can easily find the provider matching your search, including contact options.
Selected countries
Selected companies
Products
The first stop for your procurement process: discover innovative products for lab and process that make your everyday life easier and solve even complex challenges.
Products of selected companies
White papers
What could be better than an application problem that has already been solved by others? Tap into in-depth application knowledge from proven experts. Conveniently via download to your device.
Most read white papers
White papers of selected companies
Webinars
Exciting lectures and practical application tips via video, whenever you want: Our on-demand webinars make it possible. Make yourself comfortable and click play.
Selected webinars
Webinars of selected companies
Knowledge & education
Question. Answer. Find articles on 57,945 keywords in life science, biotech, pharma, biology and related science disciplines in the encyclopedia..
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.bionity.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
20-May-2005 - Chimpanzees and humans share a common ancestor, and even today 99 percent of the two species' DNA is identical. But since the paths of man and chimp diverged 5 million years ago, that one percent of genetic difference appears to have changed humans in an unexpected way: It could have made people ...
20-May-2005 - Genmab A/S announced that it has acquired rights to 16 potential targets to treat non-steroid dependent cancers of epithelial cell origin, such as gastrointestinal cancers, including colon cancer, from the insolvency administrator of Europroteome, AG, a privately owned German company currently in ...
20-May-2005 - ExonHit Therapeutics announced that its strategic alliance with Allergan, Inc. has been extended by mutual agreement based on the positive results achieved to date. This will enable both companies to continue their successful collaboration for the discovery and development of new therapeutics in ...
19-May-2005 - OncoMethylome Sciences and the Max Planck Society announced that OncoMethylome Sciences has been granted an exclusive license to intellectual property developed by the Max-Planck-Institute (MPI) of Biochemistry involving the silencing of several tumor-suppressor genes by DNA methylation ...
18-May-2005 - New preclinical data published in the current advanced online version of the journal Nature show that an experimental compound, ABT-737, that blocks the action of a class of proteins known as the Bcl-2 family, may prove to be a valuable tool in the fight against cancer. The Bcl-2 family proteins ...
18-May-2005 - Corautus Genetics Inc. and Boehringer Ingelheim Austria GmbH announced that they have entered into a long term manufacturing agreement to produce VEGF-2 (Vascular Endothelial Growth Factor 2) plasmid DNA for Phase III trials and future commercial use for the treatment of cardiovascular disease ...
17-May-2005 - Genmab A/S announced its new HuMax®-CD38 program for the treatment of multiple myeloma. HuMax-CD38 is a human IgG1,k antibody selected from a large panel of antibodies based on its ability to bind and to kill multiple myeloma tumor cells. The HuMax-CD38 antibody targets the CD38 molecule which is ...
17-May-2005 - Generex Biotechnology Corporation announced that its wholly owned subsidiary, Antigen Express, has signed an agreement with Dr. Ralph Reisfeld, Ph.D., professor of immunology at The Scripps Research Institute, to test the potency of a modified DNA vaccine for treatment of various forms of ...
13-May-2005 - Alnylam Pharmaceuticals, Inc. announced that the European Patent Office has granted Alnylam a new patent (EP Patent No. 1214945) with broad claims covering short interfering RNAs (siRNAs), the molecules that mediate RNA interference (RNAi). The new patent significantly extends the claims of the ...
13-May-2005 - Targeted Genetics Corporation announced issuance of U.S. patent #6,887,463, entitled, "Methods and Compositions for Gene Therapy for the Treatment of Defects in Lipoprotein Metabolism." This patent covers adenovirus AAV (Ad-AAV) hybrid vectors encoding the receptor for very low density ...
© 1997-2024 LUMITOS AG, All rights reserved